Jeremy Springall | Director of Physicochemical and Biophysical Methods
AstraZeneca
Jeremy Springall is Director of Biochemical and Biophysical Methods within Global Technical Operations at AstraZeneca, based in Frederick, Maryland. He leads and contributes to the development and implementation of advanced analytical approaches supporting biopharmaceutical development, manufacturing, and quality control.
Jeremy has extensive experience in analytical method development, Analytical Quality by Design (AQbD), lifecycle management, in-line and at-line monitoring, real-time release testing, laboratory automation and Design of Experiments (DoE). He is a member of the USP In-line/At-line Monitoring and Real-Time Release Testing Expert Panel and previously contributed to the IQ Consortium Analytical Quality by Design working group.
His publications and industry contributions include work on AQbD and method control, real-time testing in biopharmaceutical processes, robust analytical method development, and the use of label-free Raman spectroscopy for the rapid characterization of antibody–drug conjugates.
Appearances:
Day 1: 28th October @ 16:20
Panel: Why is Your Lab Scaling Tasks Instead of Systems?
- People tend to automate unit operation in silos without looking at the broader, end-to-end workflow- How do you prevent teams from falling into the trap of siloed automation?
- How do you bring structure to a flood of automation requests from different teams?
- What frameworks do you use to prioritize which workflows get automated first?
- What are the biggest change management hurdles when introducing automation that disrupts legacy ways of working, and how do you overcome them?
GET INVOLVED
For conference production and speaking opportunites:
For sponsorship and exhibition opportunities:
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events